"But some GLP-1 drugs are less expensive or perhaps will be soon." Image: katiko-dp/Getty Images About the Author Maureen Salamon, Executive Editor, Harvard Women's Health Watch About the Reviewer Toni Golen, MD, Editor in Chief, Harvard Women's Health Watch
Table 1) evaluating tirzepatide in people at high cardiovascular risk who are overweight or obese (without diabetes) is expected to report in 2027
Going lower shortens battery life and risks cell damage
Association between GLP-1 receptor agonist use and worsening mental illness in people with depression and anxiety in Sweden
Living with a complex chronic condition like Long COVID, ME/CFS, or dysautonomia is an exhausting, unpredictable journey
However, it is unclear whether the polymorphism of MTHFR could be an independent or an add-on risk factor for specific psychiatric symptoms, such as anxiety, depression, positive, or negative symptoms of schizophrenia, or acts as risk factor for specific psychiatric disorders, such as schizophrenia, major depression, autisms, and bipolar disorders